100 related articles for article (PubMed ID: 3036204)
1. Ascorbate depletion as a consequence of product recycling during dopamine beta-monooxygenase catalyzed selenoxidation.
May SW; Herman HH; Roberts SF; Ciccarello MC
Biochemistry; 1987 Mar; 26(6):1626-33. PubMed ID: 3036204
[TBL] [Abstract][Full Text] [Related]
2. Effects of dopamine beta-monooxygenase substrate analogs on ascorbate levels and norepinephrine synthesis in adrenal chromaffin granule ghosts.
Wimalasena K; Herman HH; May SW
J Biol Chem; 1989 Jan; 264(1):124-30. PubMed ID: 2909510
[TBL] [Abstract][Full Text] [Related]
3. Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
Padgette SR; Wimalasena K; Herman HH; Sirimanne SR; May SW
Biochemistry; 1985 Oct; 24(21):5826-39. PubMed ID: 4084493
[TBL] [Abstract][Full Text] [Related]
4. Reaction of phenylaminoethyl selenides with peroxynitrite and hydrogen peroxide.
Woznichak MM; Overcast JD; Robertson K; Neumann HM; May SW
Arch Biochem Biophys; 2000 Jul; 379(2):314-20. PubMed ID: 10898950
[TBL] [Abstract][Full Text] [Related]
5. Direct spectrophotometric detection of ascorbate free radical formed by dopamine beta-monooxygenase and by ascorbate oxidase.
Skotland T; Ljones T
Biochim Biophys Acta; 1980 Jun; 630(1):30-5. PubMed ID: 7388045
[TBL] [Abstract][Full Text] [Related]
6. Interaction of non-conjugated olefinic substrate analogues with dopamine beta-monooxygenase: catalysis and mechanism-based inhibition.
Sirimanne SR; May SW
Biochem J; 1995 Feb; 306 ( Pt 1)(Pt 1):77-85. PubMed ID: 7864832
[TBL] [Abstract][Full Text] [Related]
7. Evidence from the acceleration of cytochrome c reduction for the formation of ascorbate free radical by dopamine beta-monooxygenase.
Ljones T; Skotland T
FEBS Lett; 1979 Dec; 108(1):25-7. PubMed ID: 230081
[No Abstract] [Full Text] [Related]
8. Substrate specificity of ascorbate oxidase: unexpected similarity to the reduction site of dopamine beta-monooxygenase.
Wimalasena K; Dharmasena S
Biochem Biophys Res Commun; 1994 Sep; 203(3):1471-6. PubMed ID: 7945293
[TBL] [Abstract][Full Text] [Related]
9. Characterization of alternate reductant binding and electron transfer in the dopamine beta-monooxygenase reaction.
Stewart LC; Klinman JP
Biochemistry; 1987 Aug; 26(17):5302-9. PubMed ID: 3676254
[TBL] [Abstract][Full Text] [Related]
10. Ascorbate based novel high affinity alternate reductants and competitive inhibitors of dopamine beta-monooxygenase.
Wimalasena K; Dharmasena S; Wimalasena DS
Biochem Biophys Res Commun; 1994 Apr; 200(1):113-9. PubMed ID: 8166679
[TBL] [Abstract][Full Text] [Related]
11. The reduction of membrane-bound dopamine beta-monooxygenase in resealed chromaffin granule ghosts. Is intragranular ascorbic acid a mediator for extragranular reducing equivalents?
Wimalasena K; Wimalasena DS
J Biol Chem; 1995 Nov; 270(46):27516-24. PubMed ID: 7499210
[TBL] [Abstract][Full Text] [Related]
12. Electron transfer in chromaffin-vesicle ghosts containing peroxidase.
Harnadek GJ; Ries EA; Tse DG; Fitz JS; Njus D
Biochim Biophys Acta; 1992 Jun; 1135(3):280-6. PubMed ID: 1623014
[TBL] [Abstract][Full Text] [Related]
13. Novel antihypertensives targeted at dopamine beta-monooxygenase: turnover-dependent cofactor depletion by phenyl aminoethyl selenide.
May SW; Wimalasena K; Herman HH; Fowler LC; Ciccarello MC; Pollock SH
J Med Chem; 1988 Jun; 31(6):1066-8. PubMed ID: 3373481
[No Abstract] [Full Text] [Related]
14. Mechanism of ascorbic acid oxidation by cytochrome b(561).
Njus D; Wigle M; Kelley PM; Kipp BH; Schlegel HB
Biochemistry; 2001 Oct; 40(39):11905-11. PubMed ID: 11570891
[TBL] [Abstract][Full Text] [Related]
15. Continuous spectrophotometric assays for dopamine beta-monooxygenase based on two novel electron donors: N,N-dimethyl-1,4-phenylenediamine and 2-aminoascorbic acid.
Wimalasena K; Wimalasena DS
Anal Biochem; 1991 Sep; 197(2):353-61. PubMed ID: 1785690
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity in the dopamine beta-monooxygenase reaction. Evidence for ascorbate regulation of enzyme activity.
Stewart LC; Klinman JP
J Biol Chem; 1991 Jun; 266(18):11537-43. PubMed ID: 2050664
[TBL] [Abstract][Full Text] [Related]
17. Use of alternate substrates to probe the order of substrate addition to dopamine beta-hydroxylase.
Fitzpatrick PF; Harpel MR; Villafranca JJ
Arch Biochem Biophys; 1986 Aug; 249(1):70-5. PubMed ID: 3740855
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of dopamine-beta-hydroxylation. Semidehydroascorbate as the enzyme oxidation product of ascorbate.
Diliberto EJ; Allen PL
J Biol Chem; 1981 Apr; 256(7):3385-93. PubMed ID: 6451628
[No Abstract] [Full Text] [Related]
19. Activity of membranous dopamine beta-monooxygenase within chromaffin granule ghosts. Interaction with ascorbate.
Huyghe BG; Klinman JP
J Biol Chem; 1991 Jun; 266(18):11544-50. PubMed ID: 2050665
[TBL] [Abstract][Full Text] [Related]
20. Mechanism-based inactivation of dopamine beta-monooxygenase in adrenal chromaffin cells.
May SW; Young FK; Powers JL; Gill-Woznichak MM
Biochem Biophys Res Commun; 1996 Nov; 228(2):278-84. PubMed ID: 8920906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
